Clinical Trial Update: The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease. [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of CLZ-2002 in patients with Charcot-Marie-Tooth disease type 1 has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease Type

Drugs mentioned

• CLZ-2002

Snippet

Sponsor: Cellatoz Therapeutics, Inc | Conditions: Charcot Marie Tooth Disease, Type 1 | Phase 1 | Status: COMPLETED